Psychosocial Aspects of Multiple Endocrine Neoplasia (MEN) Syndromes

Status Completed

Clinical Trial Summary

The specific aims of the study include: 1. Profile the demographic, health-related, psychosocial and behavioral characteristics of adults with MEN1 or MEN2. 2. Evaluate MEN-specific distress as well as adherence to surveillance regimens among adults with MEN1 or MEN2, and identify associated with those outcomes.

Clinical Trial Description

The proposed cross-sectional study is intended to obtain information regarding current surveillance behaviors and other psychosocial outcomes among persons affected by the multiple endocrine neoplasia (MEN) 1 or MEN2, which are inherited conditions. Study participants will include patients who have been seen previously at MDACC for evaluation of MEN1 or MEN2. Because this is the first time investigators are contacting these patients to invite them to participate in psychosocial research, the proposed study also will help determine the feasibility of conducting similar studies in the future. Investigators anticipate that data gathered from this study will enhance existing knowledge about the psychological and behavioral aspects of the MEN syndromes, and will inform future research efforts directed toward this understudied population. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00501449
Study type	Observational
Source	M.D. Anderson Cancer Center
Contact
Status	Completed
Phase
Start date	May 2007
Completion date	September 22, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03053999` - Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
Recruiting	`NCT03048266` - Metabolomics and Genetic Diagnosing Pancreatic Neuroendocrine Tumors in MEN1 Patients
Recruiting	`NCT04028479` - The Registry of Oncology Outcomes Associated With Testing and Treatment
Terminated	`NCT00947167` - A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors	Phase 2
Completed	`NCT00204373` - Treatment of Zollinger-Ellison Syndrome With Prevacid	Phase 4
Recruiting	`NCT05812573` - A Retrospective Study for Multiple Endocrine Neoplasia
Recruiting	`NCT03348501` - Study and Follow-up of Multiple Endocrine Neoplasia Type 1	N/A
Recruiting	`NCT01793168` - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed	`NCT00990535` - High Dose Somatostatin Analogues in Neuroendocrine Tumors	Phase 2
Completed	`NCT00001277` - Studies of Elevated Parathyroid Activity	Phase 2
Completed	`NCT00001345` - Studies of Inherited Diseases of Metabolism